BNIP3L and amyloidosis: However, because we did not perform knockout experiments for BNIP3L in APP23/PS45 mice, there is insufficient evidence to confirm that BNIP3L-mediated mitophagy directly attenuates cognitive deficits and amyloidosis, with further in vivo studies required.